| __timestamp | Cytokinetics, Incorporated | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 10811000 |
| Thursday, January 1, 2015 | 19667000 | 33001000 |
| Friday, January 1, 2016 | 27823000 | 64936000 |
| Sunday, January 1, 2017 | 36468000 | 99909000 |
| Monday, January 1, 2018 | 31282000 | 127724000 |
| Tuesday, January 1, 2019 | 39610000 | 161524000 |
| Wednesday, January 1, 2020 | 52820000 | 182933000 |
| Friday, January 1, 2021 | 96803000 | 219982000 |
| Saturday, January 1, 2022 | 177977000 | 278139000 |
| Sunday, January 1, 2023 | 173612000 | 309799000 |
Data in motion
In the competitive landscape of biotechnology, understanding the financial strategies of leading companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Cytokinetics, Incorporated and Ultragenyx Pharmaceutical Inc. over the past decade. From 2014 to 2023, Ultragenyx consistently outpaced Cytokinetics in SG&A spending, with a notable peak in 2023 where their expenses reached approximately 310% of Cytokinetics' 2014 figures. This trend highlights Ultragenyx's aggressive investment in administrative and sales functions, potentially reflecting a strategy focused on rapid growth and market penetration. Meanwhile, Cytokinetics exhibited a steady increase, with a significant jump in 2022, marking a 930% rise from their 2014 expenses. This suggests a strategic pivot towards scaling operations. As these companies continue to evolve, their SG&A trends offer valuable insights into their operational priorities and market strategies.
Comparing SG&A Expenses: Novartis AG vs Cytokinetics, Incorporated Trends and Insights
Breaking Down SG&A Expenses: Viatris Inc. vs Cytokinetics, Incorporated
Summit Therapeutics Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Exelixis, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.